Surfactant system in lung cancer. Endogenous lipid pneumonia

Neoplasma

Volumn 44, Issue 3, 1997, Pages 167-171

  Sulkowska, M ^a   Sulkowski, S ^a   Chyczewski, L ^a   Niklinski J ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department of Pathological Anatomy Univ Med Sch of Bia ystok   (Poland)

Author keywords

endogenous lipid pneumonia; lung cancer

Indexed keywords

LUNG SURFACTANT;

ARTICLE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PNEUMONIA;

EID: 0030825624     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BLOBEL, G.A., MOLL, R., FRANKE, W.W., VOGT-MOYKOP, I.: Cytokeratins in normal lung and lung carcinomas. Virchows. Arch. (B), 45, 1984, 407-429.
2. COHEN, A.B., CLINE, M.J.: In vitro studies of the foamy macrophage of postobstructive endogenous lipoid pneumonia in man. Am. Rev. Respir. Dis., 106, 1972, 69-78.
3. FISHER, M., ROGGLI, V., MERTEN, D., MULVIHILL, D., SPOCK, A.: Coexisting endogenous lipoid pneumonia, cholesterol granulomas, and pulmonary alveolar proteinosis in a pediatric population: A clinical, radiographic, and pathologic correlation. Pediatr. Pathol., 12, 1992, 365-383.
4. HOMMA, S., NAGAOKA, I., ABE, H., TAKAHASHI, K., SEYAMA, K., NUKIWA, T., KIRA, S.: Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung. Am. J. Respir. Care. Med., 152, 1995, 2084-2089.
5. KASPER, M., RUDOLF, TH., VEERHOFSTAD, A.A.J., SCHUH, D., MÜLLER, M.: Heterogeneity in the immunolocalization of cytokeratin specific monoclonal antibodies in the rat lung: Evaluation of three different alveolar epithelial cell types. Histochemistry, 100, 1993, 65-71.
6. KASPER, M., SINGH, G.: Epithelial lung cell marker: Current tools for cell typing. Histol. Histopathol., 10, 1995, 155-169.
7. KUHN, III C.H., ASKIN, F.B.: Lung and mediastinum. In: Anderson's Pathology. Ed.: Kissane, J.M. New York 1985, 896-898.
8. LIBBY, P., FRIEDMAN, G.B., SALOMON, R.N.: Cytokines as modulators of cell proliferation in fibrotic diseases. Am. Rev. Respir. Dis., 140, 1989, 1114-1117.
9. MAYER, A.M.S., PITTNER, R.A.,LIPSCOMB, G.E., SPITZER, J.A: Effect of in vivo TNF administration on superoxide production and PKC activity of rat alveolar macrophages. Am. J. Physiol. (Lung Cell Mol. Physiol., 8), 264, 1993, 43-52.
10. MCDONALD, J.W., ROGGLI, V.L., BRADFORD W.D.: Coexisting endogenous and exogenous lipoid pneumonia and pulmonary alveolar proteinosis in a patient with neurodevelopment disease. Pediatr. Pathol., 14, 1994, 505-511.
11. MOLL, R., FRANKE, W.W., SCHILLER, D.L., GEIGER, B., KREPLER, R.: The catalogue of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell, 31, 1982, 11-24.
12. NATHAN, C.F.: Secretory products of macrophages. J. Clin. Invest., 79, 1987, 319-326.
13. PAINE, R., BEN-ZE'EV, A., FARMER, S., BRODY, J.S.: The pattern od cytokeratin synthesis is a marker of type II cell differentiation in adult and maturing fetal lung alveolar cells. Dev. Biol., 129, 1988, 505-515.
14. PAINE, R., GAPOSCHKIN, D., KELLY, C., VILCOXEN, S.E.: Regulation of cytokeratin expression in rat lung alveolar epithelial cells in vitro. Lung Cell. Mol. Physiol., 13, 1995, 536-544.
15. SEITZ, B., ASTOUL, P., ROBAGLIA, A., FICO, J.L., GOLSTEIN, P., BOUTIN, C.: Lipid pneumopathy and bronchopulmonary adenocarcinoma. Apropos of a case. Rev. Mal. Respir., 8, 1991, 107-109.
16. SULKOWSKA, M., SULKOWSKI, S., DZIECIOI, J.: Type II alveolar epithelial cells promote fibrosis during development of experimental lung emphysema. Folia Histochem. Cytobiol., 34, 1996, 27-28.
17. SULKOWSKA, M., SULKOWSKI, S., NOWAK, H.F., TERLIKOWSKI, S.: Type II alveolar epithelial cells and free alveolar cells after intratumor TNF-α administration. Histol. Histopathol., 11, 1996, 633-640.
18. SULKOWSKA, M., SULKOWSKI, S.: The contribution of type II pneumocytes and alveolar macrophages to fibroplasia processes in the course of enzymatic lung injury. Histol. Histopathol., 12, 1997, 111-122.
19. SULKOWSKI, S., NOWAK, H.F., CHYCZEWSKI, L.: Alveolar epithelial cells in experimental lung emphysema. Analysis of methods for type II pneumocyte identification among cells isolated from the respiratory tract of rats. J. Exp. Anim. Sci., 36, 1993/1994, 70-77.
20. SULKOWSKI, S., NOWAK, H.F., SZYNAKA, B.: Alveolar epithelial cells in experimental lung emphysema. Ultrastructural analysis of cells in situ in TEM. Exp. Toxicol. Pathol., 45, 1993/ /1994, 513-518.
21. SULKOWSKI, S., SULKOWSKA, M., TERLIKOWSKI, S.: Studies on pulmonary tissue after administration of mutein VI - hrec TNF-α into implantable experimental Morris hepatoma. Int. J. Tiss. Reac. 18, 1996, 47-53.
22. SULKOWSKI, S.: Ultrastructural analysis of the type II epithelial cells and free alveolar cells in experimental lung emphysema. Patol. Pol., 45, 1994, 63-71.
23. TERLIKOWSKI, S., NOWAK, H.F., SULKOWSKA., M., SULKOWSKI, S.: The effect of local hrec TNF-α administration upon the spontaneous lung metastases in rats with Morris 5123 hepatoma. Neoplasma, 43, 1996, 327-332.
24. VERBEKEN, E.K., DEMEDTS, M., VANWING, J., DENEFFE, G., LAUWERYNS, J.M.: Pulmonary phospholipid accumulation distal to an obstructed bronchus. A morphologic study. Arch. Pathol. Lab. Med., 113, 1989, 886-890.
25. WRIGHT, B.A., JEFFREY, P.H.: Lipoid pneumonia. Semin. Respir. Infect., 5, 1990, 314-321.